• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后女性宫颈上皮细胞中E-钙黏蛋白的表达:与激素治疗、替勃龙和雷洛昔芬的关系。

E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene.

作者信息

Sioulas Vasileios, Christodoulakos George, Lambrinoudaki Irene, Politi Ekaterini, Sergentanis Theodoros N, Creatsas George

机构信息

Menopause Clinic, 2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, Athens, Greece.

出版信息

Fertil Steril. 2008 Apr;89(4):1018-20. doi: 10.1016/j.fertnstert.2007.04.033. Epub 2007 Aug 8.

DOI:10.1016/j.fertnstert.2007.04.033
PMID:17689538
Abstract

This study assesses the possible associations between postmenopausal therapy (hormone therapy, raloxifene, and tibolone) and E-cadherin expression in normal cervical Papanicolaou smears (squamous, glandular, and metaplastic cells). E-cadherin immunostaining was less intense in metaplastic cells of women on tibolone, whereas hormone therapy and raloxifene were not associated with altered E-cadherin expression.

摘要

本研究评估绝经后治疗(激素治疗、雷洛昔芬和替勃龙)与正常宫颈巴氏涂片(鳞状细胞、腺细胞和化生细胞)中E-钙黏蛋白表达之间可能存在的关联。在使用替勃龙的女性的化生细胞中,E-钙黏蛋白免疫染色强度较低,而激素治疗和雷洛昔芬与E-钙黏蛋白表达改变无关。

相似文献

1
E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene.绝经后女性宫颈上皮细胞中E-钙黏蛋白的表达:与激素治疗、替勃龙和雷洛昔芬的关系。
Fertil Steril. 2008 Apr;89(4):1018-20. doi: 10.1016/j.fertnstert.2007.04.033. Epub 2007 Aug 8.
2
Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?激素治疗、替勃龙还是雷洛昔芬会改变宫颈上皮细胞中 VEGF 的表达吗?
Climacteric. 2012 Apr;15(2):181-5. doi: 10.3109/13697137.2011.604144. Epub 2011 Nov 8.
3
A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.一项关于激素疗法、替勃龙和雷洛昔芬对阴道出血及子宫内膜厚度影响的5年研究。
Maturitas. 2006 Mar 20;53(4):413-23. doi: 10.1016/j.maturitas.2005.07.003. Epub 2005 Sep 2.
4
Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.替勃龙治疗绝经后妇女:基于近期随机对照临床试验的综述。
Gynecol Endocrinol. 2010 Nov;26(11):804-14. doi: 10.3109/09513590.2010.495437.
5
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.激素替代疗法、替勃龙和雷洛昔芬对希腊绝经后妇女血清脂质、载脂蛋白A1、载脂蛋白B和脂蛋白(a)的影响。
Gynecol Endocrinol. 2004 May;18(5):244-57. doi: 10.1080/09513590410001715207.
6
Short and long term effects of tibolone in postmenopausal women.替勃龙对绝经后女性的短期和长期影响。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD008536. doi: 10.1002/14651858.CD008536.pub2.
7
The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS).绝经后妇女既往筛查中宫颈涂片的阳性预测值:心脏与雌激素/孕激素替代研究(HERS)
Ann Intern Med. 2000 Dec 19;133(12):942-50. doi: 10.7326/0003-4819-133-12-200012190-00009.
8
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.系统评价:降低原发性乳腺癌风险的药物比较效果。
Ann Intern Med. 2009 Nov 17;151(10):703-15, W-226-35. doi: 10.7326/0003-4819-151-10-200911170-00147.
9
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.传统及低剂量口服激素疗法(HT)、替勃龙和雷洛昔芬对活化蛋白C系统功能的不同影响。
Thromb Haemost. 2007 Jun;97(6):938-43.
10
Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women.替勃龙和雷洛昔芬对绝经后骨质减少女性骨矿物质密度的影响。
Osteoporos Int. 2008 Aug;19(8):1153-60. doi: 10.1007/s00198-007-0545-3. Epub 2008 Feb 7.